$VTYX
Ventyx Biosciences, Inc.

2021 Q4 Form 10-Q Financial Statement

#000095017021004744 Filed on November 18, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $4.002M $2.242M $245.0K
YoY Change 2909.02% 815.1%
% of Gross Profit
Research & Development $13.82M $10.55M $1.990M
YoY Change 957.69% 429.9%
% of Gross Profit
Depreciation & Amortization $16.00K $9.000K $0.00
YoY Change
% of Gross Profit
Operating Expenses $17.83M $12.79M $2.235M
YoY Change 1137.92% 472.13%
Operating Profit -$12.79M -$2.235M
YoY Change 472.13%
Interest Expense $0.00 $0.00 -$94.00K
YoY Change -100.0% -100.0%
% of Operating Profit
Other Income/Expense, Net $58.00K $13.00K -$4.920M
YoY Change -100.38% -100.26%
Pretax Income -$17.77M -$12.77M -$7.155M
YoY Change 6.38% 78.53%
Income Tax
% Of Pretax Income
Net Earnings -$17.77M -$12.77M -$7.155M
YoY Change 6.38% 78.53%
Net Earnings / Revenue
Basic Earnings Per Share -$3.17
Diluted Earnings Per Share -$363.1K -$261.1K -$146.2K
COMMON SHARES
Basic Shares Outstanding 50.30M 4.026M
Diluted Shares Outstanding 4.026M

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $258.6M $142.0M
YoY Change 105873.77%
Cash & Equivalents $70.79M $68.99M $52.00K
Short-Term Investments $187.8M $72.97M
Other Short-Term Assets $4.444M $782.0K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $263.0M $145.7M
YoY Change 107255.1%
LONG-TERM ASSETS
Property, Plant & Equipment $254.0K $219.0K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $28.15M
YoY Change
Other Assets $60.00K $2.831M
YoY Change
Total Long-Term Assets $28.46M $3.050M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $263.0M $145.7M
Total Long-Term Assets $28.46M $3.050M
Total Assets $291.5M $148.7M
YoY Change 118872.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.661M $4.263M
YoY Change 322.96%
Accrued Expenses $7.622M $7.546M
YoY Change 2432.23%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $12.28M $11.81M
YoY Change 775.48%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $0.00 $0.00
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $12.28M $11.81M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $12.28M $11.81M
YoY Change -60.25%
SHAREHOLDERS EQUITY
Retained Earnings -$117.8M -$100.0M
YoY Change 262.45%
Common Stock $5.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $279.2M -$87.62M -$13.97M
YoY Change
Total Liabilities & Shareholders Equity $291.5M $148.7M
YoY Change 118872.24%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q3
OPERATING ACTIVITIES
Net Income -$17.77M -$12.77M -$7.155M
YoY Change 6.38% 78.53%
Depreciation, Depletion And Amortization $16.00K $9.000K $0.00
YoY Change
Cash From Operating Activities -$14.70M -$11.02M -$1.882M
YoY Change 678.5% 485.44%
INVESTING ACTIVITIES
Capital Expenditures -$48.00K -$203.0K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$143.0M -$72.96M $0.00
YoY Change
Cash From Investing Activities -$143.1M -$73.16M $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 159.6M 50.38M 1.900M
YoY Change 7572.21% 2551.53%
NET CHANGE
Cash From Operating Activities -14.70M -11.02M -1.882M
Cash From Investing Activities -143.1M -73.16M 0.000
Cash From Financing Activities 159.6M 50.38M 1.900M
Net Change In Cash 1.794M -33.80M 18.00K
YoY Change 834.38% -187888.89%
FREE CASH FLOW
Cash From Operating Activities -$14.70M -$11.02M -$1.882M
Capital Expenditures -$48.00K -$203.0K $0.00
Free Cash Flow -$14.65M -$10.82M -$1.882M
YoY Change 675.95% 474.65%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001851194
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-40298
dei Entity Registrant Name
EntityRegistrantName
Ventyx Biosciences, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-2996852
dei Entity Address Address Line1
EntityAddressAddressLine1
662 Encinitas Blvd
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 250
dei Entity Address City Or Town
EntityAddressCityOrTown
Encinitas
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92024
dei City Area Code
CityAreaCode
760
dei Local Phone Number
LocalPhoneNumber
593-4832
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
VTYX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
50296506
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
68986000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
244000
CY2021Q3 us-gaap Marketable Securities
MarketableSecurities
72966000
CY2021Q3 vtyx Prepaid Expense And Other Assets Related Party
PrepaidExpenseAndOtherAssetsRelatedParty
48000
CY2020Q4 vtyx Prepaid Expense And Other Assets Related Party
PrepaidExpenseAndOtherAssetsRelatedParty
0
CY2021Q3 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
3707000
CY2020Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
1000
CY2021Q3 us-gaap Assets Current
AssetsCurrent
145659000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
245000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
219000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2831000
CY2021Q3 us-gaap Assets
Assets
148709000
CY2020Q4 us-gaap Assets
Assets
245000
CY2021Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
0
CY2020Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
238000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
4263000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1102000
CY2021Q3 vtyx Accrued Expenses Related Party
AccruedExpensesRelatedParty
237000
CY2020Q4 vtyx Accrued Expenses Related Party
AccruedExpensesRelatedParty
17000
CY2021Q3 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
0
CY2020Q3 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
107000
us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
116000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7546000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
301000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
11809000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1403000
CY2020Q4 vtyx Change Of Control Derivative Liability Related Party
ChangeOfControlDerivativeLiabilityRelatedParty
16849000
CY2020Q4 vtyx Convertible Promissory Notes Related Party
ConvertiblePromissoryNotesRelatedParty
2920000
CY2020Q4 vtyx Convertible Safe Notes At Fair Value Related Party
ConvertibleSafeNotesAtFairValueRelatedParty
9727000
CY2021Q3 us-gaap Liabilities
Liabilities
11809000
CY2020Q4 us-gaap Liabilities
Liabilities
30899000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
436248586
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
47603832
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4198682
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2187187
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4058222
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2059157
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
12393000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1847000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
17000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-100031000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-32501000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-87621000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-30654000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
148709000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
245000
CY2021Q3 vtyx Research And Development Expenses Related Party
ResearchAndDevelopmentExpensesRelatedParty
287000
CY2020Q3 vtyx Research And Development Expenses Related Party
ResearchAndDevelopmentExpensesRelatedParty
179000
vtyx Research And Development Expenses Related Party
ResearchAndDevelopmentExpensesRelatedParty
839000
vtyx Research And Development Expenses Related Party
ResearchAndDevelopmentExpensesRelatedParty
653000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10545000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1990000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
44657000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5059000
us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
328000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2242000
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
245000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4664000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
551000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
12787000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
2235000
us-gaap Operating Expenses
OperatingExpenses
49321000
us-gaap Operating Expenses
OperatingExpenses
5610000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-12787000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2235000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5862000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-12774000
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4920000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-16657000
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.17
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.58
us-gaap Operating Income Loss
OperatingIncomeLoss
-49321000
us-gaap Operating Income Loss
OperatingIncomeLoss
-5610000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
13000
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-31000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000
CY2020Q3 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
94000
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
99000
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
205000
CY2020Q3 vtyx Change In Fair Value Of Notes And Derivative Related Party
ChangeInFairValueOfNotesAndDerivativeRelatedParty
-4825000
vtyx Change In Fair Value Of Notes And Derivative Related Party
ChangeInFairValueOfNotesAndDerivativeRelatedParty
-11051000
vtyx Change In Fair Value Of Notes And Derivative Related Party
ChangeInFairValueOfNotesAndDerivativeRelatedParty
-5656000
vtyx Change In Fair Value Of Tranche Liability
ChangeInFairValueOfTrancheLiability
-5476000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
13000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-7155000
us-gaap Net Income Loss
NetIncomeLoss
-65978000
us-gaap Net Income Loss
NetIncomeLoss
-11472000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1552000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12774000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7155000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-67530000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11472000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-12774000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-7155000
us-gaap Net Income Loss
NetIncomeLoss
-65978000
us-gaap Net Income Loss
NetIncomeLoss
-11472000
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
6000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
6000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
23000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
11000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12745000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7155000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-65961000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11472000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-19.81
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-5.82
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4026083
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1998548
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3409036
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1971081
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-75864000
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
19000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
969000
CY2021Q3 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
6000
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
23000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-12774000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-87621000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-8428000
CY2020Q3 vtyx Adjustments To Additional Paid In Capital Modification Of Debt Instruments With Related Party
AdjustmentsToAdditionalPaidInCapitalModificationOfDebtInstrumentsWithRelatedParty
1601000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-7155000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-13968000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-30654000
us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
1735000
us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
2820000
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3058000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
44000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1337000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
6000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
11000
us-gaap Net Income Loss
NetIncomeLoss
-65978000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-87621000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-4128000
vtyx Adjustments To Additional Paid In Capital Modification Of Debt Instruments With Related Party
AdjustmentsToAdditionalPaidInCapitalModificationOfDebtInstrumentsWithRelatedParty
1601000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
31000
us-gaap Net Income Loss
NetIncomeLoss
-11472000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-13968000
us-gaap Profit Loss
ProfitLoss
-65978000
us-gaap Profit Loss
ProfitLoss
-11472000
us-gaap Depreciation
Depreciation
14000
us-gaap Share Based Compensation
ShareBasedCompensation
1337000
us-gaap Share Based Compensation
ShareBasedCompensation
31000
us-gaap Effect Of Exchange Rate On Cash
EffectOfExchangeRateOnCash
11000
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
99000
us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
205000
vtyx Change In Fair Value Of Notes And Derivative Related Party
ChangeInFairValueOfNotesAndDerivativeRelatedParty
-11051000
vtyx Change In Fair Value Of Notes And Derivative Related Party
ChangeInFairValueOfNotesAndDerivativeRelatedParty
-5656000
vtyx Change In Fair Value Of Tranche Liability
ChangeInFairValueOfTrancheLiability
-5476000
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
21781000
vtyx Increase Decrease In Prepaid Expense And Other Assets Related Party Amounts
IncreaseDecreaseInPrepaidExpenseAndOtherAssetsRelatedPartyAmounts
-30000
vtyx Increase Decrease In Prepaid Expense And Other Assets Related Party Amounts
IncreaseDecreaseInPrepaidExpenseAndOtherAssetsRelatedPartyAmounts
1000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3647000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-37000
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
238000
us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
259000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2049000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
932000
vtyx Increase Decrease In Accrued Liabilities Related Party Amounts
IncreaseDecreaseInAccruedLiabilitiesRelatedPartyAmounts
10000
vtyx Increase Decrease In Accrued Liabilities Related Party Amounts
IncreaseDecreaseInAccruedLiabilitiesRelatedPartyAmounts
74000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
3855000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
304000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23952000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4307000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-1899000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
72960000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
214000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-71275000
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
164221000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
746000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
44000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
450000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
4050000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
163969000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4050000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
68742000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-257000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
244000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
309000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
68986000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
52000
vtyx Amendment To Convertible Promissory Notes Related Party
AmendmentToConvertiblePromissoryNotesRelatedParty
2706000
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
38911000
us-gaap Stock Issued1
StockIssued1
21345000
vtyx Deferred Offering Costs Unpaid
DeferredOfferingCostsUnpaid
2000000
vtyx Unrealized Gain Loss On Securities Non Cash
UnrealizedGainLossOnSecuritiesNonCash
6000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1000
vtyx Number Of Acquired Wholly Owned Subsidiaries
NumberOfAcquiredWhollyOwnedSubsidiaries
2
vtyx Forward Stock Split And Reverse Stock Split Policy Policy Textblock
ForwardStockSplitAndReverseStockSplitPolicyPolicyTextblock
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">February 2021 Forward Stock Split and October 2021 Reverse Stock Split</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On February 26, 2021, the Company effected a </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7.933972</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for 1 forward stock split of its common stock. The par value and the authorized shares of the common stock were not adjusted as a result of the stock split. The accompanying condensed consolidated financial statements and notes to the condensed consolidated financial statements give retroactive effect to the stock split for all periods presented.</span></span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On October 11, 2021, the Company effected a 1 for </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_c417e5af-65bf-4ed4-b355-cef90e70565a;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.5644</span></span></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> reverse </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">stock split of its capital stock. The par value and the authorized shares of the capital stock were not adjusted as a result of the reverse stock split. The accompanying condensed consolidated financial </span></span><span style=""/></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">statements </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">and notes to the condensed consolidated financial statements give retroactive effect to the stock split for all periods presented.</span><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p></div>
us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
On February 26, 2021, the Company effected a 7.933972 for 1 forward stock split of its common stock. The par value and the authorized shares of the common stock were not adjusted as a result of the stock split. The accompanying condensed consolidated financial statements and notes to the condensed consolidated financial statements give retroactive effect to the stock split for all periods presented.
CY2021Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
7.933972
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
On October 11, 2021, the Company effected a 1 for 9.5644 reverse stock split of its capital stock. The par value and the authorized shares of the capital stock were not adjusted as a result of the reverse stock split. The accompanying condensed consolidated financial statements and notes to the condensed consolidated financial statements give retroactive effect to the stock split for all periods presented. 
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of Estimates</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the Company’s consolidated financial statements and accompanying notes. On an ongoing basis, the Company evaluates its estimates and judgments, which are based on historical and anticipated results and trends and on various other assumptions that management believes to be reasonable under the circumstances. By their nature, estimates are subject to an inherent degree of uncertainty and, as such, actual results may differ from management’s estimates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.3;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company is closely monitoring the impact of the COVID-19 pandemic on its business and has taken steps designed to protect the health and safety of its employees while continuing its operations. The full extent to which the COVID-19 pandemic will impact the Company’s business, results of operations, financial condition, clinical trials, and preclinical research will depend on future developments that are highly uncertain, including actions taken to contain or treat COVID-19 and their effectiveness, as well as the economic impact on national and international markets.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0
CY2020Q4 us-gaap Marketable Securities
MarketableSecurities
0
CY2021Q3 vtyx Fair Value Liabilities Level1 To Level2 To Level3 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2ToLevel3TransfersAmount
0
CY2021Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
72960000
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
6000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
72966000
CY2021Q3 vtyx Prepaid Research And Development Costs Current
PrepaidResearchAndDevelopmentCostsCurrent
2660000
CY2020Q4 vtyx Prepaid Research And Development Costs Current
PrepaidResearchAndDevelopmentCostsCurrent
1000
CY2021Q3 us-gaap Other Assets Current
OtherAssetsCurrent
782000
CY2021Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
217000
CY2021Q3 vtyx Prepaid Related Party Expenses Current
PrepaidRelatedPartyExpensesCurrent
48000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3707000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1000
CY2021Q3 us-gaap Deferred Costs
DeferredCosts
2768000
CY2021Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
63000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2831000
CY2021Q3 vtyx Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
4266000
CY2020Q4 vtyx Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
234000
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3043000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
50000
CY2021Q3 vtyx Accrued Related Party Liabilities Current
AccruedRelatedPartyLiabilitiesCurrent
237000
CY2020Q4 vtyx Accrued Related Party Liabilities Current
AccruedRelatedPartyLiabilitiesCurrent
17000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7546000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
301000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
0
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
231000
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
12000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
219000
CY2021Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
1899000
CY2021Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
599000
CY2021Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
16000
CY2021Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Noncurrent Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
7000
CY2021Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
802000
CY2021Q1 vtyx Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accrued Expenses
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccruedExpenses
1576000
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1337000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
31000
CY2021Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
143000
CY2021Q1 us-gaap Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
143000
CY2021Q1 vtyx Business Combination Fair Value Of Shares Issued
BusinessCombinationFairValueOfSharesIssued
21032000
CY2021Q1 vtyx Business Combination Transaction Fees
BusinessCombinationTransactionFees
577000
CY2021Q1 vtyx Business Combination Fair Value Of Vested Common Stock Options Exchanged
BusinessCombinationFairValueOfVestedCommonStockOptionsExchanged
315000
CY2021Q1 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
21924000
CY2021Q1 us-gaap Payments To Acquire In Process Research And Development
PaymentsToAcquireInProcessResearchAndDevelopment
21781000
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
0
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
969000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1547753
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.20
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y9M3D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
299000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3557803
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.18
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
92208
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.56
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
689000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.20
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
34813
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4978535
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.46
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y3M29D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
17770000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
4978535
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.46
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P9Y3M29D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
17770000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1122487
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.10
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y3M
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
7786000
us-gaap Lessee Operating Lease Option To Terminate
LesseeOperatingLeaseOptionToTerminate
the Company assumed a lease with a lease termination date of November 30, 2021 from a related party.
CY2021Q1 vtyx Lease Termination Date
LeaseTerminationDate
2021-11-30
CY2021Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P5Y
CY2021Q2 vtyx Lessee Operating Lease Effective Start Date
LesseeOperatingLeaseEffectiveStartDate
2021-07-01
CY2021Q2 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2026-06-30
CY2021Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P4Y
CY2021Q3 vtyx Lessee Operating Lease Effective Start Date
LesseeOperatingLeaseEffectiveStartDate
2021-09-16
CY2021Q3 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2026-06-30
CY2020Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
0
CY2021Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
112000
CY2021Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
382000
CY2021Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
392000
CY2021Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
370000
CY2021Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
349000
CY2021Q3 vtyx Operating Leases Future Minimum Payments Due After Year Four
OperatingLeasesFutureMinimumPaymentsDueAfterYearFour
178000
CY2021Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1783000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-12774000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-7155000
us-gaap Net Income Loss
NetIncomeLoss
-65978000
us-gaap Net Income Loss
NetIncomeLoss
-11472000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
1552000
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-12774000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7155000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-67530000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-11472000
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4026083
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1998548
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3409036
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1971081
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.17
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-3.58
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-19.81
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-5.82
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
40448671
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
12433539

Files In Submission

Name View Source Status
0000950170-21-004744-index-headers.html Edgar Link pending
0000950170-21-004744-index.html Edgar Link pending
0000950170-21-004744.txt Edgar Link pending
0000950170-21-004744-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vtyx-20210930.htm Edgar Link pending
vtyx-20210930.xsd Edgar Link pending
vtyx-20210930_cal.xml Edgar Link unprocessable
vtyx-20210930_def.xml Edgar Link unprocessable
vtyx-20210930_htm.xml Edgar Link completed
vtyx-20210930_lab.xml Edgar Link unprocessable
vtyx-20210930_pre.xml Edgar Link unprocessable
vtyx-ex10_1.htm Edgar Link pending
vtyx-ex10_2.htm Edgar Link pending
vtyx-ex31_1.htm Edgar Link pending
vtyx-ex31_2.htm Edgar Link pending
vtyx-ex32_1.htm Edgar Link pending
vtyx-ex32_2.htm Edgar Link pending